Newark Beth Israel Medical Center today announced it is enrolling patients in
a clinical study to investigate the safety and effectiveness of a new implantable
pulse generator called the Optimizer. The Optimizer System is designed to deliver
electrical impulses to the heart for treatment of moderate to severe heart failure.
This study of the Optimizer System is sponsored by Impulse Dynamics (USA) Inc.,
a specialty medical device company located in New York and a wholly-owned subsidiary
of Impulse Dynamics N.V. Newark Beth Israel Medical Center is an affiliate of
the Saint Barnabas Health Care System.